NeurAxon Inc. is a leader in discovering and developing next generation pain therapeutics focused on the inhibition of the neuronal nitric oxide synthase (nNOS) enzyme, an enzyme involved in modulating pain and central nervous system neuronal sensitization.
View Top Employees from NeurAxon Inc| Website | http://www.neuraxon.com |
| Revenue | $5 million |
| Funding | $57.3 million |
| Employees | 7 (7 on RocketReach) |
| Founded | 2004 |
| Address | 16-1375 Southdown Rd Ste 318, Mississauga, Ontario L5J 2Z1, CA |
| Phone | (905) 823-3110 |
| Technologies |
JavaScript,
HTML,
PHP
+147 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Drug Stores & Pharmacies, Biotechnology, Retail, Science and Engineering, Neuroscience, Therapeutics, Health Care |
| Competitors | BIONOMICS LIMITED, Boston Life Sciences Inc, Cognition Therapeutics, Inc., Pharmos Corporation, Step Pharma |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular NeurAxon Inc employee's phone or email?
NeurAxon Inc Questions
The NeurAxon Inc annual revenue was $5 million in 2024.
Pantelis Stanitsas is the CEO of NeurAxon Inc.
7 people are employed at NeurAxon Inc.
NeurAxon Inc is based in Mississauga, Ontario.
The NAICS codes for NeurAxon Inc are [32, 32541, 325, 3254].
The SIC codes for NeurAxon Inc are [28, 283].
Top NeurAxon Inc Employees
Related Companies
